Lv2
130 积分 2025-09-07 加入
Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma
1个月前
已完结
邹国荣, 等. 特瑞普利单抗联合化疗序贯寡转移灶巩固放疗治疗转移性鼻咽癌单臂Ⅱ期临床研究[J]. 中国肿瘤临床,2025,52(4):197-203
2个月前
已关闭
3. 陈丽, 王勇利. 卡瑞利珠单抗联合GP方案同步放化疗治疗局部晚期鼻咽癌的Ⅱ期临床研究[J]. 中华放射肿瘤学杂志,2023,32(5):412-417
2个月前
已关闭
32. Liu X, et al. Sequential chemoimmunotherapy plus consolidative SBRT for oligometastatic nasopharyngeal carcinoma: phase II trial design and preliminary efficacy[J]. Frontiers in Oncology,2024,14:1296785
2个月前
已关闭
31. 孙颖, 等. PD-1抑制剂联合化疗+转移灶巩固放疗治疗初诊寡转移鼻咽癌前瞻性Ⅱ期探索研究[J]. ESMO Open,2025,10(3):e010892
2个月前
已关闭
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial[J]
8个月前
已完结
Wang L , Bai Y , Wu M , et al. Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis[J]. Oncotarget, 2017, 8(32):52132-53141
8个月前
已完结
皖公网安备34019202002308
